Am. J. Respir. Crit. Care Med., Vol 151, No. 4, 04 1995, 1034-1039.
Endothelin in bronchoalveolar lavage fluid and its relation to airflow obstruction in asthma
AE Redington, DR Springall, MA Ghatei, LC Lau, SR Bloom, ST Holgate, JM Polak and PH Howarth
University Medicine, Southampton General Hospital, UK.
Endothelins (ETs) are a family of peptide mediators that have a number of
biological properties, including the ability to act as potent
bronchoconstrictors of isolated human airways. To examine the possible
involvement of ET in asthma, we have performed fiberoptic bronchoscopy and
bronchoalveolar lavage (BAL) on 10 healthy control subjects, 10 patients
with atopic asthma treated with bronchodilators alone, and 8 patients with
atopic asthma treated with inhaled and/or oral corticosteroids. Endothelin
concentrations in BAL fluid were measured by radioimmunoassay and total
protein concentrations by a colorimetric method. There was a significant
increase in the BAL fluid ET levels in the non-steroid-treated patients
with asthma compared with the normal subjects, when expressed either as a
concentration (median, 0.30 versus 0.08 pM; p = 0.001) or in relation to
total protein (median, 3.02 versus 1.08 pmol/g; p = 0.01). There was,
however, no statistically significant difference in ET levels between the
steroid-treated patients with asthma, and either of the other two groups.
In the non- steroid-treated patients with asthma there was a significant
negative correlation between the BAL fluid ET concentration and the %
predicted FEV1 (r = -0.71, p = 0.03). This correlation was not significant
in the steroid-treated subjects, and no correlation between BAL fluid ET
concentrations and bronchial reactivity was found in any of the three
groups. These findings are consistent with the hypothesis that ET
contributes to the pathophysiology of asthma.
This article has been cited by other articles:

|
 |

|
 |
 
D. J. Tschumperlin, J. D. Shively, T. Kikuchi, and J. M. Drazen
Mechanical Stress Triggers Selective Release of Fibrotic Mediators from Bronchial Epithelium
Am. J. Respir. Cell Mol. Biol.,
February 1, 2003;
28(2):
142 - 149.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. V. FAHY
Remodeling of the Airway Epithelium in Asthma
Am. J. Respir. Crit. Care Med.,
November 15, 2001;
164(10):
S46 - 51.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Finsnes, T. Lyberg, G. Christensen, and O. H. Skjonsberg
Effect of endothelin antagonism on the production of cytokines in eosinophilic airway inflammation
Am J Physiol Lung Cell Mol Physiol,
April 1, 2001;
280(4):
L659 - L665.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Roland, A Bhowmik, R J Sapsford, T A R Seemungal, D J Jeffries, T D Warner, and J A Wedzicha
Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease
Thorax,
January 1, 2001;
56(1):
30 - 35.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. ORDOÑEZ, R. FERRANDO, D. M. HYDE, H. H. WONG, and J. V. FAHY
Epithelial Desquamation in Asthma . Artifact or Pathology?
Am. J. Respir. Crit. Care Med.,
December 1, 2000;
162(6):
2324 - 2329.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. BOUSQUET, P. K. JEFFERY, W. W. BUSSE, M. JOHNSON, and A. M. VIGNOLA
Asthma . From Bronchoconstriction to Airways Inflammation and Remodeling
Am. J. Respir. Crit. Care Med.,
May 1, 2000;
161(5):
1720 - 1745.
[Full Text]
|
 |
|

|
 |

|
 |
 
G. W. Chalmers, E. A. Millar, S. A. Little, M. C. Shepherd, and N. C. Thomson
Effect of Infused Angiotensin II on the Bronchoconstrictor Activity of Inhaled Endothelin-1 in Asthma
Chest,
February 1, 1999;
115(2):
352 - 356.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Barnes, K. F. Chung, and C. P. Page
Inflammatory Mediators of Asthma: An Update
Pharmacol. Rev.,
December 1, 1998;
50(4):
515 - 596.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. FINSNES, G. CHRISTENSEN, T. LYBERG, O. M. SEJERSTED, and O. H. SKJONSBERG
Increased Synthesis and Release of Endothelin-1 during the Initial Phase of Airway Inflammation
Am. J. Respir. Crit. Care Med.,
November 1, 1998;
158(5):
1600 - 1606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. BARNES, S. PEDERSEN, and W. W. BUSSE
Efficacy and Safety of Inhaled Corticosteroids . New Developments
Am. J. Respir. Crit. Care Med.,
March 1, 1998;
157(3):
S1 - 53.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. W. CHALMERS, S. A. LITTLE, K. R. PATEL, and N. C. THOMSON
Endothelin-1-induced Bronchoconstriction in Asthma
Am. J. Respir. Crit. Care Med.,
July 1, 1997;
156(2):
382 - 388.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Andersson, T. A. Merritt, A. Orpana, L. Viinikka, and O. Ylikorkala
High Endothelin-1 in the Airways of Preterm Infants Is Associated With Less Severe Respiratory Distress During the Early Postnatal Period
Pediatrics,
April 1, 1997;
99(4):
545 - 547.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 American Thoracic Society
|
|
|